June 14, 2005; 64 (11) Brief Communications
Quantitative myasthenia gravis score: Assessment of responsiveness and longitudinal validity
R. S. Bedlack, D. L. Simel, H. Bosworth, G. Samsa, B. Tucker-Lipscomb, D. B. Sanders
First published June 13, 2005, DOI: https://doi.org/10.1212/01.WNL.0000163988.28892.79
R. S. Bedlack
D. L. Simel
H. Bosworth
G. Samsa
B. Tucker-Lipscomb
Quantitative myasthenia gravis score: Assessment of responsiveness and longitudinal validity
R. S. Bedlack, D. L. Simel, H. Bosworth, G. Samsa, B. Tucker-Lipscomb, D. B. Sanders
Neurology Jun 2005, 64 (11) 1968-1970; DOI: 10.1212/01.WNL.0000163988.28892.79
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 64 no. 11 1968-1970
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published June 13, 2005.
Copyright & Usage:
© 2005
Author Disclosures
- R. S. Bedlack, MD, PhD,
- D. L. Simel, MD,
- H. Bosworth, PhD,
- G. Samsa, PhD,
- B. Tucker-Lipscomb, RN, MSN and
- D. B. Sanders, MD
- R. S. Bedlack, MD, PhD,
- D. L. Simel, MD,
- H. Bosworth, PhD,
- G. Samsa, PhD,
- B. Tucker-Lipscomb, RN, MSN and
- D. B. Sanders, MD
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Brief Communications
Mycophenolate mofetil for myasthenia gravisAn analysis of efficacy, safety, and tolerabilityM.N. Meriggioli, E. Ciafaloni, K.A. Al-Hayk et al.Neurology, November 24, 2003 -
Article
IV immunoglobulin in patients with myasthenia gravisA randomized controlled trialLorne Zinman, Eduardo Ng, Vera Bril et al.Neurology, March 12, 2007 -
Views & Reviews
International Consensus Guidance for Management of Myasthenia Gravis2020 UpdatePushpa Narayanaswami, Donald B. Sanders, Gil Wolfe et al.Neurology, November 03, 2020 -
Article
Randomized study of adjunctive belimumab in participants with generalized myasthenia gravisKaren Hewett, Donald B. Sanders, Richard A. Grove et al.Neurology, March 21, 2018